Adaptation and Validation of a German Version of the Multimorbidity Treatment Burden Questionnaire
Overview
Authors
Affiliations
Background: Patients with multiple long-term conditions often face a variety of challenges arising from the requirements of their health care. Knowledge of perceived treatment burden is crucial for optimizing treatment. In this study, we aimed to create a German version of the Multimorbidity Treatment Burden Questionnaire (MTBQ) and to evaluate its validity.
Methods: The steps to translate the MTBQ included forward/back translation, cognitive interviews (n = 6) and a pilot test (n = 7). Psychometric properties of the scale were assessed in a cross-sectional survey with primary care patients aged 65 and older with at least 3 long-term conditions (n = 344). We examined the distribution of responses, dimensionality, internal reliability and construct validity.
Results: Cognitive interviewing and piloting led to minor modifications and showed overall good face validity and acceptability. As expected, we observed a positively skewed response distribution for all items. Reliability was acceptable with McDonald's omega = 0.71. Factor analysis suggested one common factor while model fit indices were inconclusive. Predefined hypotheses regarding the construct validity were supported by negative associations between treatment burden and health-related quality of life, self-rated health, social support, patient activation and medication adherence, and positive associations between treatment burden and number of comorbidities. Treatment burden was found to be higher in female participants (Mdn = 6.82, Mdn = 4.55; U = 11,729, p = 0.001) and participants with mental health diagnoses (Mdn = 9.10, Mdn = 4.55; U = 3172, p = 0.024).
Conclusions: The German MTBQ exhibited good psychometric properties and can be used to assess the perceived treatment burden of patients with multimorbidity.
Treatment burden in multimorbidity: an integrative review.
Lee J, Lee J, Shin R, Oh O, Lee K BMC Prim Care. 2024; 25(1):352.
PMID: 39342121 PMC: 11438421. DOI: 10.1186/s12875-024-02586-z.
Further development and validation of the Multimorbidity Treatment Burden Questionnaire (MTBQ).
Duncan P, Scott L, Dawson S, Munas M, Pyne Y, Chaplin K BMJ Open. 2024; 14(4):e080096.
PMID: 38604632 PMC: 11015253. DOI: 10.1136/bmjopen-2023-080096.
Vasiliauskiene O, Vasiliauskas D, Duncan P, Kontrimiene A, Jaruseviciene L, Cesnuleviciene A Eur J Gen Pract. 2023; 29(1):2284257.
PMID: 38010870 PMC: 10990257. DOI: 10.1080/13814788.2023.2284257.
Engels L, van Merode T, Heijmans M, Menting J, Duncan P, Rademakers J Fam Pract. 2023; 41(6):901-908.
PMID: 37878729 PMC: 11636562. DOI: 10.1093/fampra/cmad100.
Gebreyohannes E, Gebresillassie B, Mulugeta F, Dessu E, Abebe T Qual Life Res. 2023; 32(11):3269-3277.
PMID: 37405663 PMC: 10522511. DOI: 10.1007/s11136-023-03473-3.